FDA Clears Sorin Connect Perfusion Charting System

U.S. market clearance represents first milestone in Sorin Group’s program


August 8, 2013

August 8, 2013 — Sorin Group has received 510(k) clearance for commercialization of Sorin Connect, Sorin Group’s perfusion electronic charting system.

The new Sorin Connect perfusion electronic charting system allows real-time data recording and trends visualization aimed to support clinicians and institutions in their perfusion management and documentation goals, during and after cardiac surgery.

During the surgical case, all relevant information related to the patient and perfusion are electronically collected from Sorin’s heart lung machines and autotransfusion systems, as well as a variety of other patient monitoring devices, allowing the creation of electronic medical records (EMR) for each patient. After surgery, statistical tools are easily available for queries and analysis, supporting clinicians’ efforts towards hospital quality management and practice improvement programs.

“Connect makes data management during cardiopulmonary simple and the addition of GDP Monitor (goal directed perfusion) offers a new level of physiological control in line with goal drected therapy”, said Paul Exton, senior clinical perfusionist at University Hospital South Manchester, Manchester, U.K.

For more information: www.sorin.com